Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Where to Buy Prescription Drugs from a Top Canadian Pharmacy

Top Canadian Pharmacy Intermediary SaveRxCanada.to offer Solution to Rising Drug Costs for U.S. Patients in 2023

VANCOUVER, BC, March 29, 2023 /PRNewswire/ -- In 2023, the cost of prescription drugs in many countries remains a significant concern for consumers. As a result, many people are looking for more affordable alternatives.

Top Canadian Pharmacy intermediary SaveRxCanada.to is helping to alleviate this problem. The company is not only a trustable source for both brand name and generic drugs but consumers can save up to 70% compared to U.S. pharmacies. Their mission is to provide U.S. patients with affordable access to prescription drugs.

A recent study says the world's top country U.S. exceeds all other countries when it comes to drug spend. While U.S. pharmacies monopolize the drug market, 25% of U.S. patients face financial challenges when they buy prescription drugs.

In 2013, a U.S. customer spends $858 per year for their medications only to increase by 41.4% in 2023. For this reason, consumers can turn to a Canadian Pharmacy to get their prescription drugs at 70% lower than U.S. pharmacies.

SaveRxCanada.to can offer lower-priced prescription drugs compared to their American counterparts due to Canada's government price controls and international partnerships. According to a report by the U.S. Government Accountability Office, Americans can save up to 80% on the cost of certain prescription drugs by purchasing them from Canadian pharmacies. 

SaveRxCanada.to says "We are committed to providing U.S. patients with the best possible value for their money, while also ensuring they receive the highest quality products and exceptional customer service. Our goal is to help make prescription drugs more affordable and accessible for all U.S. patients."

About SaveRxCanada.to
SaveRxCanada.to is proud to offer a solution for U.S. patients seeking affordable access to prescription drugs. The company is dedicated to providing the best possible value, exceptional customer service, and a vast selection of generic and brand name drugs.

With the availability of more generic drugs to the market, SaveRxCanada.to's RxSelect program ensures the maximum savings for U.S. customers. This program has been running successfully for over 19 years and provides free shipping and reward points to returning patients.

For more information on how to purchase prescription drugs through this Canadian Pharmacy intermediary, please visit SaveRxCanada.to.

Customer Service
Toll-Free Calls: 1-866-799-3435 - Use ref #100048
Monday-Friday 9:00 am to 5:00 pm (EST)
All orders require a valid prescription from your doctor or physician.


This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.

SOURCE SaveRxCanada.to

These press releases may also interest you

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on June 7, 2023, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...

at 07:05
Seres Therapeutics, Inc. , a leading microbiome therapeutics company, today announced that Seres Therapeutics management, will participate in a question and answer format discussion at the Goldman Sachs Global Healthcare Conference on Monday, June...

at 07:05
Foundation Medicine Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for BRAFTOVI® (encorafenib) in combination with cetuximab which...

at 07:02
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists covering the finance industry stay on top of the week's most newsworthy and popular releases, here's a roundup of...

at 07:00
Coeptis Therapeutics Holdings, Inc. ("Coeptis" or the "Company"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today that it received approval from the Nasdaq Stock Market of the Company's request to...

at 07:00
kneat.com, inc. (the "Company" or "Kneat") , a leader in digitizing and automating validation and quality processes, is pleased to announce that it has appointed Colum McNamara as its Senior Vice President of Global Operations....

News published on and distributed by: